Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the tr…
$0.94+11.95%
报价 2026-11-13
市值
$113.9M
EV
$264.5M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -83.3%
$0.79$5.65
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CATXPerspective Therapeutics, Inc. | $113.9M | +12.0% | -54.5% | -419.4% | – | – | – | |
| AVRAnteris Technologies Global Corp. | $528.2M | -7.5% | – | 28.2% | – | – | – | |
| PROFProfound Medical Corp. | $271.8M | -0.3% | – | 71.7% | – | – | – | |
| ELMDElectromed, Inc. | $198.8M | -2.6% | – | – | – | – | – | |
| IVVDInvivyd, Inc. | $171.6M | +2.6% | +64.0% | 91.4% | – | – | – | |
| TLSITriSalus Life Sciences, Inc. | $149.9M | -3.6% | +19.9% | 85.8% | – | – | – | |
| MXCTMaxCyte, Inc. | $122.9M | 0.0% | -11.4% | 79.4% | – | – | – | |
| STIMNeuronetics, Inc. | $108M | -2.8% | +8.8% | 50.7% | – | – | – | |
| HSDTTessera Defense and Homeland Security Inc | $101M | -8.5% | +3075.0% | 95.5% | – | – | – | |
| 同行中位数 | – | – | +19.9% | 79.4% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。